Mantle Cell Lymphoma Refractory
5 clinical trials · Condition
◉ Watch Mantle Cell Lymphoma Refractory
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL (NCT05360238) | Mustang Bio | 2022-05-24 |
| Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. (NCT05645744) | Mustang Bio | 2021-09-29 |
| Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL). (NCT01389427) | The Lymphoma Academic Research Organisation | 2011-11-01 |
Track Mantle Cell Lymphoma Refractory automatically
Every clearance here is in the API, with alerts when new ones post.